Ocera Therapeutics (OCRX) 2.57 $OCRX Ocera to Present at

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ocera Therapeutics (OCRX) 2.57 $OCRX

Ocera to Present at the Jefferies 2016 Healthcare Conference
GlobeNewswire - Tue May 31, 3:05PM CDT
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that Linda Grais, M.D., Chief Executive Officer, will be presenting at the Jefferies 2016 Healthcare Conference. Ocera's presentation will take place on Friday, June 10, 2016 at 11:30 AM Eastern Time.
OCRX: 2.57 (-0.03)

Ocera to Present at the 2016 BIO International Convention
GlobeNewswire - Thu May 26, 3:05PM CDT
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that Gaurav Aggarwal, M.D., Chief Business Officer, will be presenting at the 2016 BIO International Convention being held at the Moscone Center in San Francisco, California from June 6-9, 2016. Ocera's presentation will take place on Wednesday, June 8, 2016 in Room 1 at 1:00 PM Pacific Time.
OCRX: 2.57 (-0.03)

Ocera Therapeutics Reports First Quarter 2016 Financial Results and Pipeline Progress
GlobeNewswire - Fri Apr 29, 8:05AM CDT
-- Company on target to complete enrollment in STOP-HE in the fourth quarter; approximately 165 patients enrolled to date --
OCRX: 2.57 (-0.03)

Ocera Therapeutics Announces Presentation of Two Preclinical Studies Further Supporting Its Ammonia Scavenger OCR-002 at The International Liver Congress(TM) 2016 of the European Association for the Study of the Liver (EASL)
GlobeNewswire - Fri Apr 15, 8:05AM CDT
Data establish ammonia-lowering properties of orally-administered OCR-002 in preclinical model of cirrhosis
OCRX: 2.57 (-0.03)

Ocera Therapeutics Announces Publication of Promising Preclinical Data in Support of Its Ammonia Scavenger OCR-002 in the Journal of Hepatology
GlobeNewswire - Mon Apr 11, 8:05AM CDT
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced the publication of promising preclinical data related to the Company's investigational drug candidate ornithine phenylacetate, OCR-002. The paper, entitled "Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension" is published in the April 2016 issue of the Journal of Hepatology (http://www.journal-of-hepatology.eu/article/S0168-8278(15)00777-1/abstract).
OCRX: 2.57 (-0.03)

Ocera to Present at the 15th Annual Needham Healthcare Conference
GlobeNewswire - Tue Apr 05, 3:25PM CDT
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that Linda Grais, M.D., Chief Executive Officer, will be presenting at the 15 Annual Needham Healthcare Conference being held at The Westin NY Grand Central Hotel in New York, New York from April 12-13, 2016. Ocera's presentation will take place on Wednesday, April 13, 2016 at 3:40 PM Eastern Time.
OCRX: 2.57 (-0.03)

LifeSci Capital Initiates Coverage of Ocera Therapeutics
ACCESSWIRE - Thu Mar 24, 8:58AM CDT
Developing Therapies for Serious Diseases with High Unmet Medical Need; Report Available Here: http://www.lifescicapital.com/equity-research/ocera/
OCRX: 2.57 (-0.03)

Gastroparesis Global Clinical Trials Review, H2, 2015 - Analysis, Technologies & Forecasts - Key Vendors: GlaxoSmithKline, Evoke Pharma, Ocera Therapeutics - Research and Markets
BusinessWire - Mon Mar 07, 12:04PM CST
Research and Markets (http://www.researchandmarkets.com/research/6bxkgx/gastroparesis) has announced the addition of the "Gastroparesis Global Clinical Trials Review, H2, 2015" report to their offering.
EVOK: 2.65 (+0.03), OCRX: 2.57 (-0.03), GSK: 45.25 (+0.18)

Ocera to Present at the 18th Annual BIO CEO & Investor Conference
GlobeNewswire - Tue Feb 02, 3:20PM CST
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that the Company will be presenting at the 18 Annual BIO CEO & Investor Conference taking place February 8 - 9, 2016 at the Waldorf Astoria in New York, NY. Ocera's management will present at 10:00 AM ET on Tuesday, February 9, in the Conrad room in the conference's Orphan/Rare Diseases track.
OCRX: 2.57 (-0.03)

3 Sectors to Avoid as China Stock Market Takes a Bumpy Ride
Zacks Equity Research - Zacks Investment Research - Thu Jan 14, 3:53PM CST
This time not only did the Chinese investors suffer -- stakeholders all over the world felt the heat of this market slump.
ALNY: 71.80 (+3.72), BVN: 14.90 (+0.25), OCRX: 2.57 (-0.03), IPI: 1.23 (-0.06), MIND: 3.25 (-0.11), HELI: 3.67 (-0.33)

Ocera Announces Complete Plasma Data From Pilot Phase 1 Study for Orally-Available OCR-002 in Development for the Prevention of Chronic Hepatic Encephalopathy
GlobeNewswire - Fri Jan 08, 8:05AM CST
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced further details from its Phase 1 study of oral formulations of OCR-002, ornithine phenylacetate, in healthy subjects. The Company plans to conduct additional Phase 1 testing after further formulation optimization.
OCRX: 2.57 (-0.03)

Ocera names Dr Stan Bukofzer as CMO
M2 - Fri Jan 08, 6:09AM CST
Biopharmaceutical company Ocera Therapeutics (NasdaqGM:OCRX) revealed on Thursday the addition of Dr Stan Bukofzer as its chief medical officer.
OCRX: 2.57 (-0.03)

Ocera Appoints Dr. Stan Bukofzer as Chief Medical Officer
GlobeNewswire - Thu Jan 07, 3:05PM CST
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced the appointment of Dr. Stan Bukofzer as Chief Medical Officer. Dr. Bukofzer most recently served as Chief Medical Officer of Hospira, Inc., where he was responsible for providing strategic and operational direction for clinical development, pharmacovigilance and safety and medical affairs across Hospira's three business units.
OCRX: 2.57 (-0.03)

A Refreshing Outlook -- Comprehensive Research on AU Optronics, Ocera Therapeutics, Solar3D and SUPERVALU
ACCESSWIRE - Tue Dec 22, 7:28AM CST
NEW YORK, NY / ACCESSWIRE / December 22, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: AU Optronics Corp (NYSE: AUO), Ocera Therapeutics Inc. (NASDAQ: OCRX), Solar3D Inc. (NASDAQ: SLTD) and SUPERVALU Inc. (NYSE: SVU). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
AUO: 4.15 (+0.01), SVU: 4.81 (-0.07), OCRX: 2.57 (-0.03), SLTD: 2.44 (+0.01)

Ocera Announces Positive Phase 1 Results for Oral OCR-002 in Development for the Prevention of Chronic Hepatic Encephalopathy
GlobeNewswire - Mon Nov 16, 3:05PM CST
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced positive results from the Company's Phase 1 study of the oral formulation of OCR-002, ornithine phenylacetate, in healthy subjects. OCR-002 exhibited encouraging extended-release properties, demonstrated a desirable pharmacokinetic (PK) profile and was well-tolerated.
OCRX: 2.57 (-0.03)

Ocera to Present at Stifel 2015 Healthcare Conference
GlobeNewswire - Mon Nov 09, 3:06PM CST
Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases today announced that Gaurav Aggarwal, M.D., chief business officer, will be presenting at the Stifel 2015 Healthcare Conference being held at The New York Palace Hotel in New York, NY November 17-18, 2015. Ocera's presentation will take place in the Spellman Room on Tuesday, November 17 at 4:30 PM Eastern Time.
OCRX: 2.57 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ave7® Pioneers AI-Driven Marketplace Evolution

Updated Category News Views 15

AI Reshapes the Agency Paradigm Nobody saw this coming a decade ago, but here we are—AI's taking the wheel, but with humans still riding shotgun. The agency world, particularly the one dealing with e-commerce giants like Amazon, Walmart, and Target, has flipped on its head. Ave7® steps up as the frontrunner, adapting faster than a broker's reflex after a market bell....

Continue Reading
Flexible Packaging Market to Hit $384.32B by 2031

Updated Category News Views 45

Packaging's Flexible Future Alright, here's the skinny: you might want to adjust those portfolios if you're watching the materials sector, because the flexible packaging market ain't just loosening up—it's stretching out like never before. By 2031, we're talking about it raking in a solid $384.32 billion, climbing from $313.25 billion in 2026. That's a not-so-shabby...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 67

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Giovanni Recalde Sues County After False Report

Updated Category News Views 43

Justice and Reputation: A Mix-Up Costs Big When the cops screw up, sometimes they really take the cake. That's what Giovanni Recalde learned, the hard way, when his name got tangled in a mess related to a gambling operation he wasn't even a part of. Prince William County police pasted his name into their daily incident report last year like it was no big deal. But it...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 132

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Mall of America Strives for World Record This Black Friday

Updated Category News Views 228

History in the Making at Mall of America Yeah, it seems these folks are not just about shopping anymore. The Mall of America is aiming to set the bar high this Black Friday, eyeing a GUINNESS WORLD RECORDS title for the most people holding up the same shopping bag all at once. Imagine a thousand people, synchronized like a flash mob—only with shopping bags instead of...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 69

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
Dawson Struggles With Q3 Losses Despite Growth Prospects

Updated Category News Views 74

Profit and loss dance around like a jittery stock, and Dawson Geophysical is feeling the heat this third quarter. Numbers are in, and we’re seeing a net loss of $5.2 million, translating to $0.17 per share—ouch. Not to mention a negative Adjusted EBITDA of $2 million. Compared to last year's hopes, that's a serious belly flop. Revenue Down, Hopes Up In a fetching...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 34

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading

Top 5 Most Recently Viewed Articles

BARROT Showcases Groundbreaking Bluetooth Innovations at CES

Updated Category News Views 361

BARROT Introduces Innovative Bluetooth Technologies at CES 2025 At CES 2025, held in Las Vegas, BARROT, a prominent name in short-range wireless communication, proudly showcased its latest advancements in Bluetooth technology. The highlight of BARROT's presentation is its Bluetooth v6.0-qualified stack, which integrates various cutting-edge wireless solutions including...

Continue Reading
Explore Summer Adventures Awaiting in Myrtle Beach's Shores

Updated Category News Views 264

Experience Unforgettable Summer Days in Myrtle Beach There's still plenty of time to enjoy a sun-soaked getaway the whole family will love. The sun is shining, the days are stretching on, and there remains an abundance of summer left to indulge in cherished family adventures along the beautiful coastline of Myrtle Beach. Whether you're meticulously planning your escape or...

Continue Reading
NextNRG Surges Ahead with Impressive Growth Metrics and Strategy

Updated Category News Views 194

NextNRG Achieves Extraordinary Revenue Growth AI-Driven Energy Pioneer Delivers Sixth Consecutive Record Month Company on Clear Path to $100 Million Revenue Run-Rate with Canadian Acquisition NextNRG, Inc. (Nasdaq: NXXT) is shaping the future of energy with its innovative AI-driven solutions. Recently, the company announced outstanding preliminary financial results that...

Continue Reading
Insights on IES Hldgs's Increasing Short Interest

Updated Category News Views 137

Understanding IES Hldgs's Current Short Interest Trends IES Hldgs has recently experienced a notable increase in its short interest, with the short percent of float rising by 11.11% since the last update. Investors should be aware that the latest figures indicate 673 thousand shares sold short, accounting for 7.6% of all regular trading shares. Given its current trading...

Continue Reading
ALINA Residences Celebrates Luxury VERIFIED™ Status Award

Updated Category News Views 345

ALINA Residences: A New Victory in Luxury Living ALINA Residences, located in the heart of Boca Raton, recently snagged the spotlight with its shiny new VERIFIED™ Luxury Residences plaque from Forbes Travel Guide. To most, it might just seem like a piece of metal, but in the world of upscale living, this is a badge of honor. Celebrating Commitment to Service Excellence...

Continue Reading